Literature DB >> 19623654

Quantitative detection of PML-RARalpha fusion transcript by real-time PCR with a single primer pair.

Mariko Takenokuchi1, Yuji Nakamachi, Keiko Yoneda, Kana Joo, Seiji Kawano, Eiji Tatsumi, Katsuyasu Saigo, Shunichi Kumagai.   

Abstract

Quantitative detection of minimal residual disease has prognostic value for some leukemias. Acute promyelocytic leukemia (APL) is characterized by the specific PML-RARalpha fusion gene from t(15;17). Added to three PML-RARalpha isoforms, alternative spliced forms of PML exons give rise to multiple isoforms even within a single patient. To date, multiple primer pairs for the detection of the various PML-RARalpha transcripts have been designed, potentially generating some nonspecific amplification products. Here, we established a real-time quantitative PCR (RQ-PCR) strategy with a single primer pair using LightCycler (sp-RQ-PCR), which could simultaneously detect three isoforms with equal specificity and sensitivity as well as alternative spliced forms. Results obtained with sp-RQ-PCR for 39 samples from 15 APL patients and 31 non-APL samples were compared with those with TaqMan assay with three primer pairs. In two of the APL samples, PML-RARalpha was detected in the TM, but not in the sp-RQ-PCR or nested PCR. Furthermore, the sp-RQ-PCR showed no positive results for the 31 non-APL samples, whereas the TM identified 13% (4/31) as positive. Electrophoresis detected some artifacts in the TM, which do not correspond to PML-RARalpha. We conclude that our sp-RQ-PCR is specific enough to identify various forms of PML-RARalpha and yields no false-positive results.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19623654      PMCID: PMC6649134          DOI: 10.1002/jcla.20306

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  30 in total

Review 1.  Detection of minimal residual disease in acute myeloid leukaemia: methodologies, clinical and biological significance.

Authors:  J A Yin; K Tobal
Journal:  Br J Haematol       Date:  1999-09       Impact factor: 6.998

2.  Pulsed ATRA as single therapy restores long-term remission in PML-RARalpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study.

Authors:  G Visani; S Buonamici; M Malagola; A Isidori; P P Piccaluga; G Martinelli; E Ottaviani; T Grafone; M Baccarani; S Tura
Journal:  Leukemia       Date:  2001-11       Impact factor: 11.528

3.  Over-representation of bcr3 subtype of PML/RARalpha fusion gene in APL in Indian patients.

Authors:  Sudha Sazawal; Syed Khizer Hasan; Pankhi Dutta; Bijender Kumar; Rajat Kumar; Lalit Kumar; V P Choudhry; Renu Saxena
Journal:  Ann Hematol       Date:  2005-11-12       Impact factor: 3.673

4.  Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial.

Authors:  A K Burnett; D Grimwade; E Solomon; K Wheatley; A H Goldstone
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

5.  Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR.

Authors:  B Cassinat; F Zassadowski; N Balitrand; C Barbey; J D Rain; P Fenaux; L Degos; M Vidaud; C Chomienne
Journal:  Leukemia       Date:  2000-02       Impact factor: 11.528

6.  Breakpoint clusters of the PML gene in acute promyelocytic leukemia: primary structure of the reciprocal products of the PML-RARA gene in a patient with t(15;17).

Authors:  S Dong; J P Geng; J H Tong; Y Wu; J R Cai; G L Sun; S R Chen; Z Y Wang; C J Larsen; R Berger
Journal:  Genes Chromosomes Cancer       Date:  1993-03       Impact factor: 5.006

7.  Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse.

Authors:  W Huang; G L Sun; X S Li; Q Cao; Y Lu; G S Jiang; G S Jang; F Q Zhang; J R Chai; Z Y Wang; S Waxman
Journal:  Blood       Date:  1993-08-15       Impact factor: 22.113

8.  Quantitative nested reverse transcriptase PCR vs. real-time PCR for measuring AML1/ETO (MTG8) transcripts.

Authors:  M Takenokuchi; C Yasuda; K Takeuchi; Y Nakamachi; M Mukai; S Kondo; S Kumagai; K Saigo; T Murayama; T Koizumi; E Tatsumi
Journal:  Clin Lab Haematol       Date:  2004-04

9.  Expression pattern of the RAR alpha-PML fusion gene in acute promyelocytic leukemia.

Authors:  M Alcalay; D Zangrilli; M Fagioli; P P Pandolfi; A Mencarelli; F Lo Coco; A Biondi; F Grignani; P G Pelicci
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

10.  Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17.

Authors:  J Borrow; A D Goddard; D Sheer; E Solomon
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

View more
  2 in total

1.  Development and validation of a 3-Plex RT-qPCR assay for the simultaneous detection and quantitation of the three PML-RARa fusion transcripts in acute promyelocytic leukemia.

Authors:  Zhanguo Chen; Yongqing Tong; Yan Li; Qingping Gao; Qiongyu Wang; Chaohong Fu; Zunen Xia
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

2.  FLT3/ITD associated with an immature immunophenotype in PML-RARα leukemia.

Authors:  Mariko Takenokuchi; Seiji Kawano; Yuji Nakamachi; Yasuyuki Sakota; Meilani Syampurnawati; Katsuyasu Saigo; Eiji Tatsumi; Shunichi Kumagai
Journal:  Hematol Rep       Date:  2012-10-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.